Advanced Diabetes Management Using Artificial Intelligence and Continuous Glucose Monitoring Sensors

Wearable continuous glucose monitoring (CGM) sensors are revolutionizing the treatment of type 1 diabetes (T1D). These sensors provide in real-time, every 1–5 min, the current blood glucose concentration and its rate-of-change, two key pieces of information for improving the determination of exogeno...

Descripción completa

Detalles Bibliográficos
Autores principales: Vettoretti, Martina, Cappon, Giacomo, Facchinetti, Andrea, Sparacino, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412387/
https://www.ncbi.nlm.nih.gov/pubmed/32664432
http://dx.doi.org/10.3390/s20143870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412387/
https://www.ncbi.nlm.nih.gov/pubmed/32664432
http://dx.doi.org/10.3390/s20143870

Ejemplares similares